Loading...
Keywords
Last Name
Institution

Connection

Jennifer Goldman to Pharmacovigilance

This is a "connection" page, showing publications Jennifer Goldman has written about Pharmacovigilance.

 
Connection Strength
 
 
 
2.160
 
  1. Feldman K, Suppes SL, Goldman JL. Clarification of adverse drug reactions by a pharmacovigilance team results in increased antibiotic re-prescribing at a freestanding United States children's hospital. PLoS One. 2024; 19(1):e0295410.
    View in: PubMed
    Score: 0.936
  2. Goldman JL, Chung WH, Lee BR, Chen CB, Lu CW, Hoetzenecker W, Micheletti R, Yasuda SU, Margolis DJ, Shear NH, Struewing JP, Pirmohamed M. Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement. Eur J Clin Pharmacol. 2019 Aug; 75(8):1135-1141.
    View in: PubMed
    Score: 0.671
  3. Joyner LM, Alicea LA, Goldman JL, Suppes SL, Tillman EM. Methods for Detecting Pediatric Adverse Drug Reactions From the Electronic Medical Record. J Clin Pharmacol. 2021 11; 61(11):1479-1484.
    View in: PubMed
    Score: 0.197
  4. Tillman EM, Suppes SL, Feldman K, Goldman JL. Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record. J Clin Pharmacol. 2021 02; 61(2):181-186.
    View in: PubMed
    Score: 0.185
  5. Yu D, Sheets J, Suppes S, Goldman J. Characterization of Severe Adverse Drug Reactions at a Free-Standing Children's Hospital. J Clin Pharmacol. 2019 12; 59(12):1569-1572.
    View in: PubMed
    Score: 0.171
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.